{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:39:57Z","timestamp":1792291197032,"version":"4.4.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020676","name":"IRCCS Policlinico San Donato","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Obesity adversely affects atrial fibrillation (AF) outcomes and is associated with higher recurrence after catheter ablation. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) promote weight loss and improve metabolic inflammation, but their role as adjuncts to ablation has not been completely defined. This study investigated the impact of semaglutide on post-ablation rhythm outcomes in obese patients with AF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This single-centre, propensity-matched study included obese patients [body mass index (BMI) \u2265 30\u2005kg\/m\u00b2] undergoing first-time catheter ablation for paroxysmal AF (2019\u20132024). Patients who initiated semaglutide within 3 months before or 1 month after ablation were compared with matched controls who did not receive GLP-1RA therapy. All patients underwent continuous rhythm monitoring using implantable cardiac monitors. The primary endpoint was any atrial tachyarrhythmia recurrence beyond a 2-month blanking period. The final cohort included 181 semaglutide-treated patients and 181 controls with matched clinical and procedural characteristics. At 18-month follow-up, freedom from recurrence was 80.2% vs. 65.2%; semaglutide was associated with a significantly lower risk of recurrence (hazard ratio 0.52; 95% confidence interval 0.34\u20130.78; P = 0.002). Weight and BMI decreased significantly in the semaglutide group (\u221211.8 \u00b1 3.8\u2005kg; \u22124.0 \u00b1 1.4\u2005kg\/m\u00b2) compared with controls (\u22121.9 \u00b1 1.2\u2005kg; \u22120.3 \u00b1 0.8\u2005kg\/m\u00b2; both P &amp;lt; 0.001). A substantial proportion of treated patients achieved \u226510% weight reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Glucagon-like peptide-1 receptor agonist therapy using semaglutide is associated with a reduced risk of AF recurrence in obese patients undergoing AF catheter ablation, indicating its potential as an adjunctive treatment. Further studies are needed to confirm these findings and elucidate the effects of GLP-1RA on AF recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euag018","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T12:36:25Z","timestamp":1770554185000},"source":"Crossref","is-referenced-by-count":11,"title":["Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7886-5467","authenticated-orcid":false,"given":"Giuseppe","family":"Ciconte","sequence":"first","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]},{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]},{"name":"Institute for Molecular and Translational Cardiology (IMTC), IRCCS Policlinico San Donato , San Donato Milanese, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8433-692X","authenticated-orcid":false,"given":"Raffaele","family":"Salerno","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]},{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fuga","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]},{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Vuturo","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]},{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-2675","authenticated-orcid":false,"given":"Antonio","family":"Boccellino","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]},{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-3504","authenticated-orcid":false,"given":"Gabriele","family":"Negro","sequence":"additional","affiliation":[{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-8902","authenticated-orcid":false,"given":"Roberto","family":"Rondine","sequence":"additional","affiliation":[{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ballarotto","sequence":"additional","affiliation":[{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Ciaccio","sequence":"additional","affiliation":[{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Izzo","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]},{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7669-4139","authenticated-orcid":false,"given":"Davide Antonio","family":"Morciano","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]},{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1093-4657","authenticated-orcid":false,"given":"Arianna","family":"Garbelli","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-9476","authenticated-orcid":false,"given":"Luigi","family":"Giannelli","sequence":"additional","affiliation":[{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2543-8583","authenticated-orcid":false,"given":"Vincenzo","family":"Maiolo","sequence":"additional","affiliation":[{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarko","family":"Calovic","sequence":"additional","affiliation":[{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0712-2161","authenticated-orcid":false,"given":"Luigi","family":"Anastasia","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]},{"name":"Institute for Molecular and Translational Cardiology (IMTC), IRCCS Policlinico San Donato , San Donato Milanese, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0901-6135","authenticated-orcid":false,"given":"Carlo","family":"Pappone","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University , Milan ,","place":["Italy"]},{"name":"Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato , Piazza E. Malan 1, San Donato Milanese, Milan 20097 ,","place":["Italy"]},{"name":"Institute for Molecular and Translational Cardiology (IMTC), IRCCS Policlinico San Donato , San Donato Milanese, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026021708363052200_euag018-B1","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"2026021708363052200_euag018-B2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2026021708363052200_euag018-B3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026021708363052200_euag018-B4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacasi.2024.08.021","article-title":"Combination of body mass index and waist circumference burden determines the risk of atrial fibrillation","volume":"5","author":"Rhee","year":"2025","journal-title":"JACC Asia"},{"key":"2026021708363052200_euag018-B5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026021708363052200_euag018-B6","doi-asserted-by":"crossref","first-page":"932262","DOI":"10.3389\/fcvm.2022.932262","article-title":"Epicardial adipose tissue and cardiac arrhythmias: focus on atrial fibrillation","volume":"9","author":"Conte","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026021708363052200_euag018-B7","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jacc.2021.08.037","article-title":"Modulation of cardiac arrhythmogenesis by epicardial adipose tissue: JACC state-of-the-art review","volume":"78","author":"Ernault","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026021708363052200_euag018-B8","doi-asserted-by":"crossref","first-page":"e032277","DOI":"10.1161\/JAHA.123.032277","article-title":"Impact of obesity on atrial fibrillation pathogenesis and treatment options","volume":"13","author":"Sha","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026021708363052200_euag018-B9","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/j.hrthm.2025.03.1999","article-title":"One-year clinical and safety outcome of obese patients undergoing pulmonary vein isolation for atrial fibrillation with pulsed field ablation or cryoballoon ablation: a propensity-matched analysis","volume":"22","author":"Feickert","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026021708363052200_euag018-B10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/heartjnl-2018-313490","article-title":"Impact of body mass index on the outcome of catheter ablation of atrial fibrillation","volume":"105","author":"Glover","year":"2019","journal-title":"Heart"},{"key":"2026021708363052200_euag018-B11","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"},{"key":"2026021708363052200_euag018-B12","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2026021708363052200_euag018-B13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jacc.2024.05.065","article-title":"Effect of semaglutide on epicardial adipose tissue in type 2 diabetes: insights from the STOP (semaglutide treatment effect on coronary atherosclerosis progression) randomized trial","volume":"84","author":"Manubolu","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026021708363052200_euag018-B14","doi-asserted-by":"crossref","first-page":"103067","DOI":"10.1016\/j.dsx.2024.103067","article-title":"Semaglutide for the prevention of atrial fibrillation: a systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2024","journal-title":"Diabetes Metab Syndr"},{"key":"2026021708363052200_euag018-B15","doi-asserted-by":"crossref","first-page":"e14292","DOI":"10.1111\/eci.14292","article-title":"Glucagon-like peptide-1 receptor agonist semaglutide reduces atrial fibrillation incidence: a systematic review and meta-analysis","volume":"54","author":"Saglietto","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"2026021708363052200_euag018-B16","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1007\/s12325-024-02959-x","article-title":"Effects of glucagon-like peptide 1 receptor agonists on atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis","volume":"41","author":"Karakasis","year":"2024","journal-title":"Adv Ther"},{"key":"2026021708363052200_euag018-B17","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jacep.2024.03.031","article-title":"Effects of glucagon-like peptide-1 receptor agonists on atrial fibrillation recurrence after catheter ablation","volume":"10","author":"Satti","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2026021708363052200_euag018-B18","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"2026021708363052200_euag018-B19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/fca-2021-0002","article-title":"Biosense Webster\u2019s QDOT MicroTM radiofrequency ablation catheter","volume":"17","author":"Wielandts","year":"2021","journal-title":"Future Cardiol"},{"key":"2026021708363052200_euag018-B20","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae263","article-title":"Anatomical-guided third-generation laser balloon ablation for the treatment of paroxysmal atrial fibrillation assessed by continuous rhythm monitoring: results from a multicentre prospective study","volume":"26","author":"Ciconte","year":"2024","journal-title":"Europace"},{"key":"2026021708363052200_euag018-B21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jacep.2021.02.014","article-title":"Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II","volume":"7","author":"Reddy","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2026021708363052200_euag018-B22","doi-asserted-by":"crossref","first-page":"e011780","DOI":"10.1161\/CIRCEP.122.011780","article-title":"Paroxysmal atrial fibrillation ablation using a novel Variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study","volume":"16","author":"Duytschaever","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026021708363052200_euag018-B23","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae134","article-title":"State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective","volume":"26","author":"Chun","year":"2024","journal-title":"Europace"},{"key":"2026021708363052200_euag018-B24","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"2026021708363052200_euag018-B25","doi-asserted-by":"crossref","first-page":"e012253","DOI":"10.1161\/JAHA.119.012253","article-title":"Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study","volume":"8","author":"Provid\u00eancia","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026021708363052200_euag018-B26","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae157","article-title":"Ablation registration committee of the Netherlands Heart Registration. Body mass index and pulmonary vein isolation: real-world data on outcomes and quality of life","volume":"26","author":"Vermeer","year":"2024","journal-title":"Europace"},{"key":"2026021708363052200_euag018-B27","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.jacep.2023.04.023","article-title":"Impact of obesity on catheter ablation of atrial fibrillation: in-hospital and 30-day outcomes","volume":"9","author":"Tan","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2026021708363052200_euag018-B28","doi-asserted-by":"crossref","first-page":"999845","DOI":"10.3389\/fcvm.2022.999845","article-title":"Body mass index and atrial fibrillation recurrence post ablation: a systematic review and dose-response meta-analysis","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026021708363052200_euag018-B29","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae204","article-title":"Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"2026021708363052200_euag018-B30","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.3390\/jcm14092919","article-title":"Beyond pulmonary vein reconnection: exploring the dynamic pathophysiology of atrial fibrillation recurrence after catheter ablation","volume":"14","author":"Vlachakis","year":"2025","journal-title":"J Clin Med"},{"key":"2026021708363052200_euag018-B31","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf085.401","article-title":"Left atrial intramyocardial fat at pulmonary vein reconnection sites during atrial fibrillation redo ablation","volume":"27","author":"Landra","year":"2025","journal-title":"Europace"},{"key":"2026021708363052200_euag018-B32","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1161\/CIRCULATIONAHA.120.052009","article-title":"Extracellular vesicles from epicardial fat facilitate atrial fibrillation","volume":"143","author":"Shaihov-Teper","year":"2021","journal-title":"Circulation"},{"key":"2026021708363052200_euag018-B33","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026021708363052200_euag018-B34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.acvd.2020.03.023","article-title":"Impact of obesity on atrial fibrillation ablation","volume":"113","author":"Mangiafico","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"key":"2026021708363052200_euag018-B35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.hrthm.2017.02.023","article-title":"Impact of obesity on atrial fibrillation ablation: patient characteristics, long-term outcomes, and complications","volume":"14","author":"Winkle","year":"2017","journal-title":"Heart Rhythm"},{"key":"2026021708363052200_euag018-B36","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2017.09.002","article-title":"Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise","volume":"70","author":"Lavie","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026021708363052200_euag018-B37","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021708363052200_euag018-B38","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamacardio.2025.4007","article-title":"Aggressive risk factor reduction study for atrial fibrillation implications for ablation outcomes: the ARREST-AF randomized clinical trial","volume":"10","author":"Pathak","year":"2025","journal-title":"JAMA Cardiol"},{"key":"2026021708363052200_euag018-B39","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae298","article-title":"Spotlight on the 2024 ESC\/EACTS management of atrial fibrillation guidelines: 10 novel key aspects","volume":"26","author":"Rienstra","year":"2024","journal-title":"Europace"},{"key":"2026021708363052200_euag018-B40","doi-asserted-by":"crossref","first-page":"e038882","DOI":"10.1161\/JAHA.124.038882","article-title":"Catheter ablation of atrial fibrillation in patients with psoriasis: a multicenter study","volume":"14","author":"Compagnucci","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026021708363052200_euag018-B41","doi-asserted-by":"crossref","first-page":"910256","DOI":"10.3389\/fendo.2022.910256","article-title":"Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"13","author":"Wei","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026021708363052200_euag018-B42","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"2026021708363052200_euag018-B43","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"2026021708363052200_euag018-B44","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jacc.2024.08.023","article-title":"Atrial fibrillation and semaglutide effects in obesity-related heart failure with preserved ejection fraction: STEP-HFpEF program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026021708363052200_euag018-B45","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/jce.16737","article-title":"Long-term impact of GLP-1 receptor agonists on AF recurrence after ablation in obese patients","volume":"36","author":"Patel","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026021708363052200_euag018-B46","first-page":"e69008","article-title":"Semaglutide versus other glucagon-like peptide-1 agonists for weight loss in type 2 diabetes patients: a systematic review and meta-analysis","volume":"16","author":"Wen","year":"2024","journal-title":"Cureus"},{"key":"2026021708363052200_euag018-B47","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE-\/- and LDLr-\/- mice by a mechanism that includes inflammatory pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2026021708363052200_euag018-B48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2213-8587(22)00085-7","article-title":"Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial","volume":"10","author":"Heise","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026021708363052200_euag018-B49","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1038\/s41467-024-51076-4","article-title":"A neuronal circuit driven by GLP-1 in the olfactory bulb regulates insulin secretion","volume":"15","author":"Montaner","year":"2024","journal-title":"Nat Commun"},{"key":"2026021708363052200_euag018-B50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10741-024-10450-6","article-title":"GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction","volume":"30","author":"Bonfioli","year":"2025","journal-title":"Heart Fail Rev"},{"key":"2026021708363052200_euag018-B51","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa2502280","article-title":"Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation","volume":"392","author":"Reichlin","year":"2025","journal-title":"N Engl J Med"},{"key":"2026021708363052200_euag018-B52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.31083\/j.rcm2506205","article-title":"Efficacy and safety of laser balloon versus irrigated radiofrequency ablation as initial therapies for atrial fibrillation: a meta-analysis","volume":"25","author":"Chen","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"2026021708363052200_euag018-B53","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacep.2023.09.015","article-title":"Efficacy of pulsed field vs radiofrequency for the reablation of chronic radiofrequency ablation substrate: redo pulsed field ablation","volume":"10","author":"Younis","year":"2024","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euag018\/66845000\/euag018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/2\/euag018\/66845000\/euag018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/2\/euag018\/66845000\/euag018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:36:42Z","timestamp":1771335402000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euag018\/8471681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euag018","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,2]]},"article-number":"euag018"}}